Using evidence on city-level policies to encourage collateralization in the early 2000s, we find that government efforts to encourage the practice sparked much of China's increase in patent ...

Black Friday is approaching, but this sale at Amazon already has a bunch of awesome Black Friday-worthy deals. If you're on the hunt for holiday gifts, a new TV, or new apparel to refresh your ...

There's not too much longer to wait until Black Friday, but you can beat the rush with this awesome JBL sale at Amazon. Some of our favorite speakers and headphones have been slashed in price.

This week, OpenAI quietly published a statement on its website pledging not to use its patents offensively. Asserting its commitment to the principles of “broad access” and “collaboration ...

It's almost that time. Black Friday deals will be here before you know it and Walmart is getting a headstart with a massive sale on last year's Black Friday best-sellers. You can score record-low ...

Ahead of release, the Kuwaiti authorities have taken action and banned the new FPS game from sale. In a statement to CharlieINTEL, Activision says Black Ops 6 hasn’t been approved to launch in ...

French PV manufacturer Carbon says it is leading a consortium that has filed a patent opposition against JA Solar’s tunnel oxide passivated contact (TOPCon) patent at the European Patent Office ...

Abolkheir's editorial identifies a logical fallacy embedded within the 'non-obviousness' requirement in patent law, a flaw that had gone unnoticed until now. Dr. Abolkheir has termed this the ...

GSK’s latest lawsuit adds to a complex legal battle over COVID-19 vaccines, including an August 2022 patent infringement suit from Moderna against Pfizer and BioNTech. The mRNA specialist at the time ...

At the time, Pfizer voiced confidence in its patent position and vowed to “vigorously defend against” the allegations. Meanwhile, GSK last August filed a separate lawsuit against Pfizer over ...

Oct 15 (Reuters) - Voting technology company Smartmatic convinced a U.S. appeals court on Tuesday to uphold its win against a patent infringement lawsuit brought by rival Election Systems & Software.

Exelixis (NASDAQ:EXEL) jumped 9% after a win in a patent fight with generic drug make MSN Laboratories over Cabometyx. The asserted claims of the Malate Salt Patents are not invalid, Judge Richard G.